Comparison of Bupivacaine plus magnesium sulphate with Ropivacaine plus magnesium sulphate local infiltration of wound for most op analgesia
Not Applicable
- Conditions
- Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere
- Registration Number
- CTRI/2019/04/018833
- Lead Sponsor
- Dr Anuja Agrawal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age >18 years <60 years
ASA-I, II and III
Patient willing to sign informed consent.
Mallampatti class I and II
Upper abdominal surgeries eg. Open Cholecystectomy, Laprotomies, upper abdominal wall mass, etc.
Exclusion Criteria
Patientâ??s refusal.
ASA IV
Mallampatti class III and IV
Known allergy of any of the drugs
Patient not planned for extubation after the surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain the analgesic synergy of bupivacaine and magnesium sulfate in postoperative pain management?
How does ropivacaine plus magnesium sulfate compare to standard-of-care analgesics for upper abdominal surgery patients?
Are there specific biomarkers that predict enhanced analgesic response to local infiltration with bupivacaine or ropivacaine combined with magnesium sulfate?
What are the potential adverse events associated with magnesium sulfate adjuvant in local anesthetic wound infiltration?
What alternative adjuvants to bupivacaine and ropivacaine are being explored for postoperative analgesia in gallbladder and biliary tract disorders?